‡ these authors contributed equally to this work Nanog, Sox2, and Oct4 are transcription factors all essential to maintaining the pluripotent embryonic stem cell phenotype. Through a cooperative interaction Sox2 and Oct4 have previously been described to drive pluripotent-specific expression of a number of genes. We now extend the list of Sox2-Oct4 target genes to include Nanog. Within the Nanog proximal promoter we identify a composite sox-oct cis-regulatory element essential for Nanog pluripotent transcription. This element is conserved over 250 million years of cumulative evolution within the eutherian mammals. A Nanog proximal promoter-EGFP reporter transgene recapitulates endogenous Nanog mRNA expression in embryonic stem cells and their differentiated derivatives. Sox2 and Oct4 interaction with the Nanog promoter was confirmed through mutagenesis and in vitro binding assays. Electrophoretic mobility shift assays indicate the Sox2-Oct4 heterodimer forms more efficiently on the composite element within Nanog than the similar element within Fgf4. Using chromatin immunoprecipitation, we show that Oct4 and Sox2 bind to the Nanog promoter in living mouse and human embryonic stem cells. Furthermore, by specific knockdown of Oct4 and Sox2 mRNA by RNAi in embryonic stem cells we provide genetic evidence for a link between Oct4, Sox2, and the Nanog promoter. These studies extend the understanding of the pluripotent genetic regulatory network within which the Sox2-Oct4 complex are at the top of the regulatory hierarchy.
Nanog is a homeobox-containing transcription factor with an essential function in maintaining the pluripotent cells of the inner cell mass (ICM 1 ) and in the derivation of embryonic stem cells (ESCs) from these (1) . Furthermore, over-expression of Nanog is capable of maintaining the pluripotency and self-renewing characteristics of ESCs under what normally would be differentiation-inducing culture conditions (2) . Concomitant with this essential function in pluripotent cell maintenance is its restricted expression pattern. Nanog transcripts first appear in the inner cells of the morula prior to blastocyst formation (1, 2) , are restricted to the ICM in the blastocyst (3) , and are no longer detectable at implantation. Expression of Nanog reappears in the proximal epiblast at embryonic day 6 and remains restricted to the epiblast as development progresses (4) . The factors controlling expression of this gene have yet to be described.
The POU domain-containing Oct4 and the HMG domain-containing Sox2 are two other transcription factors known to be essential for normal pluripotent cell development and maintenance (5, 6) . Although both have independent roles in determining other cell types (6, 7) , at least part of their function in pluripotent cells is via a synergistic interaction between the two to drive transcription of target genes. Currently known targets of Sox2-Oct4 synergy are Fgf4, Utf1, Fbx15 and Sox2 and Pou5f1 (the gene encoding Oct4), themselves (8) (9) (10) (11) (12) (13) ). Each of these target genes has a composite element containing an octamer and a sox binding site. Our recent characterization of a genetic link between the Sox2-Oct4 complex and Sox2 and Pou5f1 expression, as well as their in vivo binding to these genes in mouse and human ESCs (12) suggests that this complex is at the top of the pluripotent cell genetic regulatory network.
In this study we were interested in identifying the cis-regulatory module responsible for the pluripotent-specific expression of Nanog. Nanog represents the first known transcription factor appearing after compaction and specific to the inner cells of the morula, both Oct4 and Sox2 are expressed prior to compaction in all blastomeres (6, 14) . As Nanog's expression precisely corresponds to the pluripotent phenotype we reasoned that a molecular understanding of this gene's regulation would provide further insight into pluripotency. Here we describe a cisregulatory module conserved throughout the eutherian mammals that is capable of recapitulating endogenous Nanog expression, at the core of this module is a composite oct-sox element necessary for pluripotent expression.
Materials and Methods
Sequence Analysis & Promoter Constructs -All sequences were from public data bases at www.ncbi.nlm.nih.gov and/or www.ensembl.org. Genomic sequence corresponding to Homo sapien NANOG (15) was used. Bos taurus (cow) and Loxodonta africana (elephant) sequences were constructed from trace files available at NCBI. Mus musculus (mouse) and Rattus norvegicus (rat) sequences were from the respective compiled genomic sequences. The promoter region of mouse Nanog was amplified from genomic DNA. Primers for amplification, with restriction sites for cloning purposes indicated in lowercase, were: forward CGCgtcgacTAAAGTGAAATGAGGTAAAGCC and reverse CGCggatccGGAAAGATCATAGAAAGAAGAG . The amplified product was cloned into pGL3-Basic (Promega) and pEGFP1 (Clontech) vectors and sequence-verified. Embryonic Stem Cell Culture and Reporter Lines -E14 mouse ESCs were grown in DMEM, 20% FBS, 1X nonessential amino acids, 0.1 mM 2-mercaptoethanol, and an aliquot of recombinant LIF conditioned media. ESCs were stably transfected with the NanogEGFP construct using a standard protocol and individual colonies picked after selection with 300 ug/ml G418 for 10 days with cells grown on neomycin-resistant mouse embryonic fibroblasts. Differentiation of ESCs was by withdrawal of LIF-conditioned media, spontaneous differentiation into embryoid bodies, or by addition of retinoic acid. Fluorescence activated cell sorting (FACS) was on a FACSCalibur (BD Biosciences). Quantitation of endogenous Nanog and EGFP reporter expression was by RT-PCR analyses in real time using the ABI PRISM 7900 Sequence Detection System. Proligo synthesized primer-probe sets for these were as follows: Nanog forward, GGTTGAAGACTAGCAATGGTCTGA; Nanog reverse, TGCAATGGATGCTGGGATACTC; Nanog probe, TTCAGAAGGGCTCAGCACCA; EGFP forward, CGACAACCACTACCTGAGCAC; EGFP reverse, TCGTCCATGCCGAGAGTGAT; EGFP probe, CGGCGGCGGTCACGAACTCCAGC. Expression was normalized to a b-actin control (ABI). The human ESC line HUES-6 (obtained from Doug Melton, Harvard University) was passaged according to Cowan et al (16) . Luciferase Reporter Assays -F9 cells (ATCC) were cultured in DMEM with high glucose (Gibco), 15% standard FBS (Hyclone), and 1% pen/strep and maintained at 37°C with 5% CO 2 . DNA transfection was by Lipofectamine 2000 (Invitrogen) following the company's protocol. A renilla luciferase plasmid (pRL-TK from Promega) was co-transfected as an internal control. Cells were harvested after 24 hours and the luciferase activity of the lysate measured with the Dual-Luciferase Reporter Assay System (Promega) using the Centro LB960 96-well luminometer (Berthold Technologies). At a minimum, transfections were done in duplicate and on two independent occasions. Reporter plasmids were modified using the Transformer site-directed mutagenesis kit (Clontech) to incorporate 3 bp mutations which were subsequently verified by sequencing. Electrophoretic Mobility Shift Assays (EMSA) -Nuclear extracts were prepared from E14 mouse ESCs grown on mouse embryonic fibroblast (MEF) feeders using the method of Dignam et al. (17) with modifications as described: cells were washed and harvested by scraping in PBS, resuspended in 5 pellet volumes (vol) of buffer A (10 mM Hepes pH 7.9, 1.5 mM MgCl 2 , 10 mM KCl, 0.5 mM DTT, 1% Protease Inhibitor Cocktail (Sigma)) and incubated on ice for 10 min. Cells were resuspended in 2 vol buffer A and lysed with a Dounce homogenizer. Pelleted nuclei were resuspended in 0.6 vol buffer C (20 mM Hepes pH 7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl 2 , 0.2 mM EDTA, 0.5 mM DTT, 1% Protease Inhibitor Cocktail) and incubated at 4°C with rotation for 30 min. After centrifugation supernatants were dialyzed against dialysis buffer (20 mM Hepes pH 7.9, 20% glycerol, 100 mM KCl, 0.83 mM EDTA, 1.66 mM DTT, 1% Protease Inhibitor Cocktail) at 4°C for 2 h. Extracts were then stored at -80°C.
For EMSA dsDNA oligonucleotides (Proligo) labeled with cy5 at the 5' termini of both strands were used. Sense strand sequences were as follows: FOS-TTTAAGTATCCCATTAGCATCCAAACAAAG  AGTTTTC,  NOS-CTTACAGCTTCTTTTGCATTACAATGTCCA  TGGTGGA,  NmOS-CTTACAGCTTCTTTCAAATTACAATGTCCA  TGGTGGA,  NOmS-CTTACAGCTTCTTTTGCATTAACCTGTCCAT  GGTGGA,  NmOmS-CTTACAGCTTCTTTCAAATTAACCTGTCCA  TGGTGGA, NNS-CTGCAGGTGGGATTAACTGTGAATTCA. For DNA-binding reactions 2 µl (~16 µg) of nuclear extract was added to a 10 µl reaction (final) containing 50 nM cy5 oligonucleotide and 5 µg poly-dGdC (Amersham). The final binding buffer composition was 60% dialysis buffer. Where specified 1 µM unlabeled ds competitor was also included prior to addition of nuclear extracts. Binding reactions were incubated for 20 min at RT. Where specified antibodies (Santa Cruz) were added after the initial incubation for a further 20 min as follows: 2 µl anti-Oct4 (sc-9081x) and antiJunB (sc-46x) or 8 µl anti-Sox2 (sc-17320) and anti-Sox4 (sc-17326). Binding reactions were resolved on pre-run 6% native PAGE gels (18.5 x 20 cm) in 0.5X TBE for 2 h at 300 V. Gels were imaged directly in glass plates using a Molecular Dynamics Typhoon 9140 phosphoimager. EMSA performed with MEF feeders alone produced no significant mobility shifts indicating they did not contribute to the observed protein-DNA complexes. Chromatin Immunoprecipitation (ChIP) AssayChIP assays with E14 mouse ESCs were carried out as described (18). Briefly, cells were crosslinked with 1% formaldehyde for 10 min at RT and formaldehyde inactivated by addition of 125 mM glycine. Chromatin extracts containing DNA fragments with average size of 500 bp were IPed using Oct4 (N19) or Sox2 (Y17) polyclonal antibodies (Santa Cruz Biotechnology) or a Sox2 (AB5603) polyclonal antibody (Chemicon). For all ChIP experiments quantitative PCR analyses was performed in real time using ABI PRISM 7900 Sequence Detection System and SYBR Green Master Mix as described (19) . Relative occupancy values were calculated by determining the apparent IP efficiency (ratios of the amount of IPed DNA over that of the input sample) and normalized to the level observed at a control region, which was defined as 1. 
RESULTS
Sequence Comparisons Identify Conserved NonCoding Sequences -As Nanog is expressed in both mouse and human pluripotent cells we reasoned the pluripotent transcription of this gene is maintained through the functional conservation of cis-regulatory elements, and concomitantly, the location and sequence of these elements would be conserved through purifying selection. Therefore we extracted mouse and human Nanog genomic sequences from the public databases. A pair-wise alignment of the mouse and human gene sequences was generated utilizing the Vista online tool at LBL Berkley (20) . We aligned the genomic region from 10 kb upstream of the most 5' mouse Nanog EST to 10 kb downstream of the most 3' EST. Peaks of sequence similarity corresponded to the four exons of Nanog, most significantly in the homeodomain-encoding exons 2 and 3 (data not shown). Of the 26.1 kb of noncoding sequence that we compared the only area of significant sequence conservation was a 200 bp region immediately upstream of the 5'-most EST. This focused our attention on this region for further study as the sequence conservation suggested functionally conserved cis-regulatory elements.
Proximal Promoter is Sufficient to Recapitulate
Endogenous Expression -To functionally test this conserved proximal promoter region we generated stably transfected mouse ESC lines with a plasmid vector containing the mouse sequence from -289 to +117 (relative to the transcription start site (TSS)) driving the expression of an enhanced green fluorescent protein (EGFP). We had defined the Nanog TSS as the position of the furthest 5' public EST, this has since been defined as the predominant TSS (4). After G418 selection for stably transfected ES lines the majority of colonies fluoresced green indicating this region of the Nanog promoter is indeed active in pluripotent cells (see Fig. 1B ). A number of these NanogEGFP colonies were selected for further analysis.
In addition to the pluripotent positive cisregulatory elements within this promoter fragment we were interested in determining whether this promoter contained sufficient cis-regulatory information to down-regulate transcription upon ESC differentiation as occurs with endogenous Nanog. Therefore we compared EGFP expression in the undifferentiated NanogEGFP ESCs to their differentiated derivatives (Fig. 1 ). Retinoic acid (RA), a strong inducer of ESC differentiation, drastically reduced EGFP expression after 3 days of treatment (Fig. 1E,F) . Culturing NanogEGFP cells in the absence of LIF, a less aggressive differentiation protocol than RA, reduced EGFP expression noticeably after 3 days of culture ( Fig.  1C-D ). This expression pattern was seen in 3 independent NanogEGFP lines.
To directly compare transcripts from this NanogEGFP to that of the endogenous Nanog itself we used realtime PCR (Fig. 1G) . The EGFP expression closely paralleled that of the endogenous Nanog as indicated in comparisons of embryoid bodies of 2, 4, 6, and 8 days as well as 2 and 4 days after induction with RA or exclusion of LIF from the media. In addition, the percentage of EGFP-positive cells, as determined by FACS analysis, in this NanogEGFP reporter line under differing differentiation conditions correlated well with endogenous Nanog expression (Fig. 1G ). For instance the undifferentiated ESCs were 74% EGFP-positive whereas the 8-day embryoid bodies and 4-day RA treated cells were 3% and 9% EGFP-positive, respectively. These results indicate this 406 bp fragment of Nanog contains sufficient cis-regulatory information to recapitulate endogenous Nanog expression, at least as tested in an in vitro ESC-based system.
Phylogenetic Footprinting Identifies an Oct-Sox
Composite Element -We next aimed to identify the specific cis-regulatory elements responsible for driving pluripotent expression. Generating an alignment of the proximal promoter region from a diverse range of mammals enabled us to identify a strong phylogenetic footprint. A very conservative estimate of the divergence time between the five species used in constructing this alignment (12 million years ago (mya) for the mouse-rat split and 60 mya between each of the mouse-rat, human, cow, and elephant) provides a cumulative 252 million years of purifying selection to identify a footprint. The greatest stretch of sequence conservation was over a 94 bp region located from position -212 to -119 relative to the Nanog TSS; within this 64 positions were invariant (Fig. 2A) .
A 16 bp stretch represented the longest uninterrupted invariant sequence and, intriguingly, within this was a 15 bp oct-sox composite element ( Fig. 2A ) similar to those identified in and known to be functional for pluripotent expression of Fgf4, Utf1, Sox2, Pou5f1 and Fbx15 (8) (9) (10) (11) (12) . The position of the sox and oct elements relative to each other is the same in all five of these genes which is indicative of the specific protein-protein contacts between the corresponding transcription factors (Sox2 and Oct4) known to bind this composite element (21, 22) . Similar to Utf1, Sox2, Pou5f1 and Fbx15, the sox and oct cis-elements in Nanog are immediately adjacent to one another whereas in Fgf4 3 bases separate the two elements.
Such strong purifying selection at numerous positions within the Nanog promoter suggests a functional role for these positions in the regulation of transcription. Some of these positions, such as the oct-sox composite element, are likely to be important in pluripotent expression while others may represent cis-reulatory elements functional in the post-implantation expression of Nanog.
Functional Analysis of the Conserved cisRegulatory Module -To study the role of specific sequence elements in the activation of pluripotent cell transcription we constructed a series of luciferase reporter constructs and transfected these into F9 teratocarcinoma cells, a mouse cell line representative of the pluripotent phenotype. The wild-type 406 bp promoter (-289 to +117) from the NanogEGFP construct had significant transcriptional activity in this system; its activity was set arbitrarily to 100% for all further comparisons (wt, Fig. 2B ). A shorter region (-230 to +63) still inclusive of the conserved sequence in Fig. 2A had approximately 130% activity of the original promoter. This suggests a potential negative regulatory element contained within the -289 to -231 region that is excluded from this shorter promoter but also indicates the presence of pluripotent activator elements within the -230 to +63 span.
To test the orientation dependence of the conserved module we made identical constructs but with a region (spanning -289 to -94) containing this module in either forward or reverse orientation relative to the immediate proximal promoter (-93 to +117). Restriction enzymes introduced when creating these two constructs slightly altered the sequence from that of the wildtype control. 79% of wild-type activity was maintained in the forward and 48% in the reverse construct. This luciferase data is summarized from a total of 4 different experiments with 3 wells of cells/construct/experiment. Though significant transcriptional activity was maintained in the reverse orientation it did consistently show a lower transcriptional activity than the forward (wildtype) orientation which suggests this conserved module's function has subtle orientation effects.
The Oct and Sox cis-Elements are Required for
Nanog Promoter Activity -To test their effect on pluripotent transcriptional activity 3 bp mutations were generated within this core conserved region ( Fig. 2A) . The M2, M3, and M4 mutations, cumulatively covering 7 invariable positions of the 9 bp they span, did not greatly alter transcriptional activity (Fig. 2B) . The M3 mutation did not decrease promoter activity and the M2 and M4 mutations dropped luciferase activity down to approximately 65% of wild-type. These subtle effects on promoter activity may indeed be significant in the context of the in vivo pluripotent cell. It is also possible that these positions covered by the M2, 3, and 4 mutations have some other functional role (as they are conserved) other than activation of transcription in pluripotent cells, possibly in the repression of expression in a Nanog-negative cell type or activation of transcription in Nanog-positive cells that occur later in development.
As anticipated mutations effecting the oct and sox elements dropped promoter activity to 17 and 15 %, respectively (Fig. 2B) , additionally when both of these sites were mutated in the same construct activity was reduced to 6% of wild-type. A conserved sequence 20 bp 5' to the oct-sox composite element also had a very drastic effect on transcription (M1, Fig. 2B ) lowering it to 22% of wild-type. This suggests the oct and sox cisregulatory elements are not the only elements important in pluripotent transcription of Nanog and highlights the utility of phylogenetic footprinting for identifying functionally important cis-regulatory elements. However, our subsequent analysis focused on the sox and oct elements themselves.
Sox2 and Oct4
Bind the Composite cis-ElementTo determine whether Oct4 and Sox2 were able to recognize the composite element within the Nanog promoter we performed EMSA using a 37 bp probe (NOS) spanning this sequence combined with nuclear extracts from mouse ESCs. The Fgf4 enhancer element (FOS) known to bind Oct4 and Sox2 in EMSA (see 8) was used as a positive control. Four major protein-DNA complexes (A-D) were observed using the NOS probe (Fig. 3) . Similar complexes appeared on the FOS probe with one additional complex (E)
formation is favored on the Nanog element relative to the Fgf4 element. This is corroborated by the observation that the ratio of the intensity of the heterodimer complex (C) to that of the Oct4 monomer complex (A) was consistently greater on NOS compared to FOS (Fig. 3) .
We also observed a consistently faster mobility of the Oct4/Sox2 heterodimer binding NOS compared to that binding FOS. This is compatible with the idea that a more closed conformation could occur on the NOS sequence due to the lack of nucleotides separating the oct and sox elements, as occurs in the FOS sequence. It is tempting to speculate that such distinct conformations could result in a differential recruitment of co-regulatory factors and a differential transcriptional activity.
Competitions with unlabeled ds oligos established the DNA-binding specificity of Oct4 and Sox2 on the Nanog element. First, binding by all factors to NOS or FOS was strongly competed by addition of a 20-fold excess of the identical unlabeled oligo while a non-specific unlabeled oligo containing a downstream sequence from the Nanog promoter (NNS) did not compete (Fig. 3) . Further indication that similar complexes were forming on the two elements was evidenced from the ability of the unlabeled FOS to compete with binding to labeled NOS and vis versa. To further characterize the binding specificity of Oct4 and Sox2 we used competitors in which the Nanog sequence contained 3 bp substitutions (as in Fig.  2A ) in either the oct (NmOS), sox (NOmS), or in both (NmOmS) elements. Unlabeled NmOS was unable to compete effectively for binding of the Oct4 monomer or the Sox2-Oct4 heterodimer on either NOS or FOS while Sox2 binding was competed on the FOS element. Likewise, the Sox2 monomer and the heterodimer were able to bind both NOS and FOS in the presence of NOmS while binding of the Oct4 monomer was competed. Moreover the competitor with substitutions in both elements, NmOmS, did not effectively compete for binding of Oct4, Sox2 or the heterodimer to either NOS or FOS. Taken together these results establish that binding of Oct4 requires an intact octamer motif, binding of Sox2 requires an intact sox element and binding of the heterodimer requires that both be intact.
It is noteworthy that both NmOS and NOmS partially competed for heterodimer formation as would be predicted since they bind the Sox2 and Oct4 monomers respectively. Significantly, following disruption of the heterodimer on NOS by competition of Oct4 binding by NOmS, the Sox2 monomer was able to bind NOS. This further establishes that Sox2 can bind the Nanog element as a monomer and that in the absence of competitor all of the available Sox2 in E14 extracts binds this element as a heterodimer with Oct4, suggesting that heterodimer formation is favored on this element.
Oct4 and Sox2 Bind to the Nanog Promoter in vivo and Regulate its Activity -To confirm that
Oct4 and Sox2 do interact with the Nanog promoter in vivo we performed chromatin immunoprecipitation (ChIP) experiments with Oct4 and Sox2 antibodies and nuclear extracts from mouse and human ESCs, and in mouse ESCs differentiated with retinoic acid. From undifferentiated mouse ESCs grown in feeder-free conditions DNA fragments containing the composite oct-sox element were enriched up to 43-fold and 37-fold when immunoprecipitated with the Oct4 and Sox2 antibodies, respectively (Fig. 4A, amplicons 2) . Two neighbouring regions that did not contain the oct-sox composite element were not significantly enriched (Fig. 4A,  amplicons 1 and 3) . Furthermore, upon retinoic acid induced differentiation of mouse ESCs this enrichment of the oct-sox containing fragments was reduced corresponding to the degree of differentiation. After 3 days of differentiation enrichment only reached a maximum of 10-fold above background with both Oct4 and Sox2 antibodies and after 6 days of differentiation no significant enrichment was detectable (Fig. 4A) . Using an MLL antibody as a negative control there was no significant enrichment for any of the amplicons from any of the three ESC states analyzed (data not shown). The level of enrichment identified here corresponds well with the activity of the Nanog promoter in a similar differentiation protocol described above with the EGFP reporter line.
To establish that OCT4 and SOX2 also interact with the NANOG promoter in human ESCs we performed a similar ChIP analysis on the human ESC line HUES-6, these grown on inactivated mouse embryonic fibroblasts. We used six different amplicons (Fig. 4B) , all within close proximity to exon 1 of NANOG, to detect for enrichment of DNA ChIPed with OCT4 and SOX2 antibodies. Only the three closest amplicons to the composite sox-oct element showed significant enrichment with both antibodies (Fig.  4B) . A second Sox2 antibody (Y17) gave similar results (data not shown). The lower foldenrichment for all three antibodies (approximately 6-fold) compared to that seen in mouse ESCs may be due to the presence of more differentiated cells within the human culture as undifferentiated hESCs tend to be more difficult to maintain in culture. Using a GST antibody as a negative control there was no significant enrichment for any of the amplicons in these human ESCs (data not shown). In summary, all this ChIP data clearly indicates in vivo occupancy of Oct4/OCT4 and Sox2/SOX2 on the Nanog/NANOG promoter in undifferentiated mouse and human ESCs.
In order to establish the functional importance of Oct4 and Sox2 on Nanog promoter activity, we performed RNAi experiments to reduce the level of Oct4 or Sox2. Both Pou5f1 and Sox2 RNAi constructs used in this study were previously shown to specifically knock down their respective mRNAs (12) . We co-transfected a Nanog-luciferase reporter construct with either Pou5f1, Sox2, GFP, or empty RNAi constructs (Fig. 5A) into mouse ESCs and subsequently assayed for luciferase activity. Luciferase activity was reduced to almost that of background levels with the Pou5f1 and Sox2 RNAi whereas the GFP and empty RNAi controls had no effect (Fig. 5B) . These results establish a genetic link between the pluripotent activity of the Nanog proximal promoter and the levels of Sox2 and Oct4.
DISCUSSION
Here we have characterized the proximal promoter of Nanog and established that the region from -289 to +117 relative to the transcription start site contains sufficient cis-regulatory information to recapitulate endogenous Nanog expression, at least as seen in undifferentiated ESCs and their differentiated derivatives. Within this promoter we identified a composite sox-oct cis-regulatory module necessary for pluripotent expression and show that the pluripotent transcription factors Sox2 and Oct4 bind this module both in vitro and in living mouse and human ESCs. This data is the first to directly link these three transcription factors within the pluripotent cell genetic regulatory network. Furthermore, as Nanog is known to be essential for the pluripotent phenotype (1,2) our data further emphasizes the position of the Sox2-Oct4 complex at the top of the pluripotent regulatory network hierarchy.
Concurrent to our investigation reported here, Kuroda et al. (23) also describe Sox2 and Oct4 binding, respectively, to the sox and octamer elements within the Nanog promoter. Their data largely corroborate our findings but with some minor yet significant differences.
Kuroda et al. observed Sox2/Oct4 heterodimers binding to the Nanog sox-oct element by EMSA in nuclear extracts harvested from F9 cells and from an embryonic germ (EG) cell line but not in the R1 mouse ES cell line. Instead, in the R1 cells they observed an unidentified Oct/Sox element binding factor which they named PSBP (Pluripotent cell-specific Sox element-binding protein) that they suggest binds cooperatively with Oct4 via an interaction with the sox element. This binding activity was present in R1 ES cell nuclear extracts but not observed in the F9 or EG cells. In contrast we did not observe any significant differences between binding activities in F9 or our E14 mouse ES nuclear extracts (data not shown). The reason for this difference is unclear but may represent a difference between the R1 and E14 ES cells used or may be due to the different conditions used in the EMSA experiment. Significantly, in our EMSA experiments we used 5 µg of the non-specific DNA competitor poly-dGdC as compared to 2 µg used by Kuroda et al. suggesting that binding by PSBP may require less stringent binding conditions.
Furthermore they suggest that a competition between Sox2 and PSBP for heterodimerization with Oct4 on sox-oct elements might occur and that PSBP is favored in ES cells, putting into question the requirement of Sox2 for Nanog transcription in ES cells. Our results clearly establish that Sox2 is required for the ES cellspecific expression as when it is knocked-down by RNAi Nanog transcription is severely compromised ( Figure 5 ).
One final difference is that they were unable to detect binding of the Sox2 monomer to the Nanog sox-oct element when either endogenously or exogenously expressed. They attribute this to a low sequence-specific DNAbinding affinity. In contrast, while we did not detect the Sox2 monomer in E14 nuclear extracts binding to the Nanog sox-oct element, we did observe Sox2 binding both when it was expressed exogenously in NIH 3T3 cells (data not shown) and endogenously in E14 nuclear extracts when the Oct4/Sox2 heterodimer was disrupted by competition with the unlabelled NOmS (Figure 3 ). This indicates that Sox2 does have an adequate affinity for the Nanog sox-oct element to be detected by EMSA and that in E14 extracts the Sox2 monomer is not observed binding because the heterodimer is highly favored. This is supported by comparing the EMSA using the Nanog element with the element in Fgf4 ( Figure  3) . The 3bp spacing between the sox and octamer elements of Fgf4 leads to a decrease in cooperative binding by the heterodimer so that the Sox2 monomer can be readily detected. Kuroda et al. on the other hand do not observe any differences on Sox2 binding between the sox-oct elements of Nanog or Fgf4. Nanog is one of six genes to be identified as a target of Sox2-Oct4 synergism in pluripotent cells ( Table 1 ). The corresponding sox-oct composite element fits the classical description of an enhancer element as within these six target genes it is orientation and location independent.
We show that within the Nanog promoter this element is transcriptionally active in either orientation (Fig. 2) . Furthermore, there is no apparent association between location and orientation of the sox-oct composite element and the expression level of the corresponding gene (Table 1) as measured by massively parallel signature sequencing in mouse ESCs (24) .
Considering the apparently allowable sequence variation within the sox-oct composite element between the six target genes (Table 1) it is then surprising to see the invariant nature of this element in the Nanog promoter over an accumulated 250 million years of evolution. This conservation strongly suggests a functional requirement for this exact sequence; this may be through maintaining a precise dissociation constant of the Sox2-Oct4 complex on this element that is functionally important and/or an allosteric effect that this ligand may have on the binding of potential co-activators to the bound complex. There is yet no evidence for an allosteric effect but certainly binding affinities of Sox2 and Oct4 on this composite element have been shown to differ between the target genes. For instance, here we characterized differences between elements from Nanog and Fgf4, with the heterodimer binding more efficiently to Nanog. This may reflect sequence differences within the sox and oct sites between these genes but also likely results from the additional 3 bp separating these sites in Fgf4. Additionally, unlike all other targets the element from Fbx15 is unable to bind Oct4 as a monomer (10) . Certainly subtle variations on the level of Nanog are known to lead to different cell fates (25) and as such its gene's level of transcription must be tightly regulated.
The identification of the sox-oct element in Nanog from the African elephant suggests that the Sox2-Oct4 complex drives Nanog transcription in all eutharian mammals, as the elephant represents the most distal clade within this group of mammals. During our data base searches we identified the chick homolog of Nanog (ensemble ID: ENSGALG00000014319, and Unigene ID: Gga.16924), interestingly this gene did not contain any identifiable sox-oct composite element suggesting that chick Nanog transcription is not regulated by the Sox2-Oct4 complex. Furthermore, the repeating tryptophan residues in the C-terminal end of mammalian Nanog, which are known to be involved in a potent transcriptional activation function in pluripotent cells (26), are not present in chick Nanog. Apparently Nanog has evolved uniquely mammalian features (and possibly restricted to the eutherian mammals) both with respect to transcriptional regulation and protein function. This raises interesting questions with regards to the evolution of the mammalian pluripotent cell transcriptional network.
The fact that Nanog transcripts are apparently present in the initial formation of the mouse blastocyst in conceptuses lacking Oct4 (2) appears counterintuitive to our results but may be an indication that the molecular mechanisms activating the initial transcription of Nanog during development are different to those regulating maintenance of its expression in the pluripotent cell. The committed pluripotent cell in which Nanog has an essential function in maintaining, cells such as the ESC and those found in the epiblast of the expanded blastocyst, are developmentally distinct from their totipotent precursors. Though Nanog transcripts first appear in the inner cells of the morula, cells in the preimplantation mouse conceptus do not become committed to either the trophoblast or epiblast lineage until after blastocyst formation (27, 28) .
This epiblast commitment, something that does not occur in Oct4 null blastocysts (5), may be associated with the onset of Oct4 regulation of Nanog.
Here we have directly implicated Oct4 and Sox2 in the regulation of Nanog; this remains a rather simplistic view of the transcriptional regulation of Nanog. Both Oct4 and Sox2 are present in the nucleus of Nanog-negative cells of the morula and their precursors (6, 14) indicating other molecular signals, besides the appropriate cellular location of Oct4 and Sox2, are required for pluripotent-specific expression of Nanog. Indeed this may explain why we did not see transactivation of a Nanog promoter-luciferase reporter construct in co-transfection experiments with Oct4 and Sox2 expression constructs in 293 and 3T3 cells (data not shown). We are currently addressing whether these additional molecular signals are mediated through other cis-elements within this conserved promoter (such as the M1 site characterized above) and/or through coactivators interacting with the Oct4/Sox2 complex. Further characterization of this cis-regulatory module will continue to enhance our understanding of the pluripotent stem cell genetic regulatory network. , and EGFP (as a control) were co-transfected with a Nanog promoter-luciferase reporter construct (A) into mouse ESCs and assayed for luciferase activity 3 days after transfection (B). A construct without inhibitory RNA was used as a negative control (-). Luciferase activity was measured relative to the Renilla luciferase internal control. Standard deviations are indicated. 
